UPDATE: Deutsche Bank Reiterates Hold Rating, Raises PT on Acadia Healthcare Company

In a report published Monday, Deutsche Bank reiterated its Hold rating on Acadia Healthcare Company

, and slightly raised its price target from $23.00 to $24.00. Deutsche Bank noted, “Raising forecasts to reflect recent deals. We have updated our model to reflect the recent BCA and AmiCare deals. We assume they contribute ~$120M of revenue and ~$25M of EBITDA in year 1. Our model also reflects the recent financing and assumes that ACHC's borrowing capacity is increased to consummate the transactions later this year. The model reflects the deals contributing effective Q1 2013, however, we have modest dilution reflected Q4 2012 due to the timing of the equity raise.” Acadia Healthcare Company closed on Friday at $22.03.